Finance

Lists
Why is BDTX down ၃.၂၈%?
Dive Deeper
BDTX:NASDAQ
Black Diamond Therapeutics Inc
၁.၇၇ US$
-၃.၂၈%
(-၀.၀၆၀) 1D
၁.၇၇ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDTX...
Open
၁.၈၆ US$
High
၁.၈၆ US$
Low
၁.၇၆ US$
Mkt. cap
၁၀.၁၇ ကုဋေ
Avg. vol.
၅.၉၁ သိန်း
Volume
၃.၇၈ သိန်း
52-wk high
၄.၉၄ US$
52-wk low
၁.၆၀ US$
EPS
-၀.၇၄ US$
Beta
၃.၃၂
Shares outstanding
၅.၇၅ ကုဋေ
No. of employees
၂၁
Open
၁.၈၆ US$
High
၁.၈၆ US$
Low
၁.၇၆ US$
Mkt. cap
၁၀.၁၇ ကုဋေ
Avg. vol.
၅.၉၁ သိန်း
Volume
၃.၇၈ သိန်း
52-wk high
၄.၉၄ US$
52-wk low
၁.၆၀ US$
EPS
-၀.၇၄ US$
Beta
၃.၃၂
Shares outstanding
၅.၇၅ ကုဋေ
No. of employees
၂၁
News stories
From web sources and news partners
Business Wire
Business Wire
·
ပြီးခဲ့သည့် ၁၆ မိနစ်
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quiver Quantitative
Quiver Quantitative
·
ပြီးခဲ့သည့် ၂၆ မိနစ်
SKK Holdings Closes Rantizo Asset Purchase, Will Rename Company and Trade on Nasdaq as Rantizo Under Ticker RNTZ
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ နာရီ
3 things to look out for on Tuesday (SP500:)
About Black Diamond Therapeutics Inc
CEO-
Employees၂၁
Founded၂၀၁၄
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to BDTX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BDTX in the last 3 months.
Highest
Current ၁.၇၇ US$
၁၄.၀၀ US$ (+၆၉၀.၉၆%)
Average
၁၀.၃၃ US$ (+၄၈၃.၆၂%)
Lowest
၈.၀၀ US$ (+၃၅၁.၉၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean McCutcheon
Raymond James
Buy
Maintained
၁၁.၀၀ US$
+၅၂၁.၅%
08/06/2026
Maury Raycroft
Jefferies
Buy
Maintained
၁၀.၀၀ US$
+၄၆၅%
08/06/2026
Robert Driscoll
Wedbush
Buy
Reiterated
၁၄.၀၀ US$
+၆၉၁%
08/06/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
၈.၀၀ US$
+၃၅၂%
08/06/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
၈.၀၀ US$
+၃၅၂%
08/06/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၁၁.၀၀ US$
+၅၂၁.၅%
08/06/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/05/2026
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q2 2026
-၀.၁၇ US$ / -၀.၂၀ US$
+၁၅.၀၀%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၇.၄၄ သန်း
၆.၃၀ သန်း
၇.၀၀ သန်း
၇.၃၉ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၅၄ သန်း
၃.၉၇ သန်း
၄.၂၆ သန်း
၄.၆၆ သန်း
Operating expense
၁.၁၀ ကုဋေ
၁.၀၃ ကုဋေ
၁.၁၃ ကုဋေ
၁.၂၁ ကုဋေ
Total operating expenses
၁.၁၀ ကုဋေ
၁.၀၃ ကုဋေ
၁.၁၃ ကုဋေ
၁.၂၁ ကုဋေ
Operating income
-၁.၁၀ ကုဋေ
-၁.၀၃ ကုဋေ
-၁.၁၃ ကုဋေ
-၁.၂၁ ကုဋေ
Other non operating income
၁.၃၂ သန်း
၁.၁၆ သန်း
၁.၂၀ သန်း
၁.၂၃ သန်း
EBT including unusual items
-၈.၅၀ သန်း
-၁.၅၁ ကုဋေ
-၉.၀၄ သန်း
-၉.၉၀ သန်း
EBT excluding unusual items
-၈.၅၀ သန်း
-၇.၉၂ သန်း
-၉.၀၄ သန်း
-၉.၉၀ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၈.၅၀ သန်း
-၁.၅၁ ကုဋေ
-၉.၀၄ သန်း
-၉.၉၀ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၅
-၀.၁၄
-၀.၁၆
-၀.၁၇
Interest and investment income
၁.၁၆ သန်း
၁.၁၈ သန်း
၁.၀၂ သန်း
၉.၂၂ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၁၆ သန်း
၁.၁၈ သန်း
၁.၀၂ သန်း
၉.၂၂ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၉ ကုဋေ
-၁.၀၂ ကုဋေ
-၁.၁၂ ကုဋေ
-၁.၂၀ ကုဋေ
Gain or loss from assets sale
-၁.၀၀ ထောင်
-၃.၀၀ ထောင်
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ